Farther Finance Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
+11,882
New +$2.23M 0.02% 682
2026
Q1
Sell
-11,333
Closed -$2.08M 5764
2025
Q4
$2.08M Buy
11,333
+6,219
+122% +$1.09M 0.02% 565
2025
Q3
$785K Buy
5,114
+1,462
+40% +$221K 0.01% 849
2025
Q2
$510K Buy
3,652
+610
+20% +$85.5K 0.01% 898
2025
Q1
$442K Buy
3,042
+353
+13% +$51.1K 0.01% 838
2024
Q4
$352K Sell
2,689
-12
-0.4% -$1.68K 0.01% 736
2024
Q3
$421K Sell
2,701
-104
-4% -$16.8K 0.02% 668
2024
Q2
$437K Buy
2,805
+871
+45% +$131K 0.02% 523
2024
Q1
$260K Sell
1,934
-37
-2% -$4.9K 0.02% 597
2023
Q4
$265K Buy
1,971
+939
+91% +$122K 0.02% 483
2023
Q3
$140K Buy
1,032
+202
+24% +$27.6K 0.02% 459
2023
Q2
$119K Sell
830
-85
-9% -$12.5K 0.03% 410
2023
Q1
$127K Buy
915
+151
+20% +$20.3K 0.04% 347
2022
Q4
$104K Buy
+764
New +$95.8K 0.04% 322

Other funds holding AZN

Farther Finance Advisors's AZN Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 11,882 shares worth $2.25M. The stake represents 0.02% of the portfolio and ranks #682 among its holdings. This is a return to the name: Farther Finance Advisors previously reported a position in AZN as recently as Q4 2025.

Farther Finance Advisors first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 406 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Farther Finance Advisors held 11,882 shares of AstraZeneca worth $2.25M as of Q2 2026.
  • AstraZeneca was a new Farther Finance Advisors position in Q2 2026.
  • AstraZeneca made up 0.02% of Farther Finance Advisors's portfolio in Q2 2026, its #682 holding.
  • Farther Finance Advisors first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
  • 406 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.